WhereYouGoThereYouAre

Spread words of wisdom for all to enjoy and hold.

[WhereYouGoThereYouAre @TeabiscuitB]

$MIKP - Amended Securities Registration (section 12(g)) (10-12g/a) https://t.co/nsu51Q1PsL

[WhereYouGoThereYouAre @TeabiscuitB]

$ATAI - Proxy Statement (definitive) (def 14a) https://t.co/gSXEAqVwTS

[WhereYouGoThereYouAre @TeabiscuitB]

$ATAI - atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at https://t.co/Zm5EbpUMp5

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - MindMed to Participate in May Investor Conferences https://t.co/njPBRKiTDn

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Amended Statement of Changes in Beneficial Ownership (4/a) https://t.co/QOXsweDDDv

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Amended Statement of Changes in Beneficial Ownership (4/a) https://t.co/Z66KINyMSC

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Amended Statement of Changes in Beneficial Ownership (4/a) https://t.co/RktsqzrFON

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) https://t.co/2YszNK2XVP

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - FCM Nominates Exceptional Director Candidates to Restore MindMed’s Value https://t.co/8VQmWlRcoZ

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Current Report Filing (8-k) https://t.co/FgS41JIJHd

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting https://t.co/Qf1yjSciox

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Proxy Statement - Contested Solicitations (preliminary) (prec14a) https://t.co/UN3NG7DY73

[WhereYouGoThereYouAre @TeabiscuitB]

$ATAI - Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) https://t.co/RF1CQU6elI

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Statement of Changes in Beneficial Ownership (4) https://t.co/hDwzUnDkTZ

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Initial Statement of Beneficial Ownership (3) https://t.co/ujDLjYdPeU

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - Current Report Filing (8-k) https://t.co/5vxmORIvGT

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major https://t.co/1Z5hhsu2Uk

[WhereYouGoThereYouAre @TeabiscuitB]

$ATAI - atai Life Sciences Announces First Subject Dosed in the Phase 1 IV-to-Subcutaneous Bridging Study of https://t.co/BmzaLsMzOx

[WhereYouGoThereYouAre @TeabiscuitB]

$MNMD - MindMed Appoints Mark R. Sullivan as Chief Legal Officer and Corporate Secretary https://t.co/xKGBSgWnnq

[WhereYouGoThereYouAre @TeabiscuitB]

$MIKP - Withdrawal of Registration Statement (ammendment) (aw) https://t.co/BxJ3NawNoD